RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > China-Focused USP Committee to Develop Excipient Standards

China-Focused USP Committee to Develop Excipient Standards

Posted 29 November 2011

The US Pharmacopeia (USP) is creating a China-focused East Asia expert committee to develop quality standards for excipients.  In June, the USP released details regarding its plans to create a free, online collection of voluntary public standards, called the Medicines Compendium (MC).  Development of these first ten standards was shaped by comments from USP staff and the MC South Asia expert committee.  USP chose to create its first MC-focused body in South Asia due to India's central role in exporting medicines.  The next committee is forming in East Asia and will be composed of Chinese scientists.  Initially, the committee will focus on developing quality standards for excipients. (In-Pharma Technologist)


© 2022 Regulatory Affairs Professionals Society.